Lv4
424 积分 2021-04-24 加入
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
27天前
已完结
Antibody-Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
29天前
已完结
Cross-priming underlies the efficacy of antibody–drug conjugates and immunotherapy combinations
29天前
已完结
Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
1个月前
已完结
Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer
4个月前
已完结
Novel antibody-drug conjugates based on DXd-ADC technology
4个月前
已完结
962 A novel CD2-targeted costimulatory bispecific antibody platform for enhancing CD3 T cell engager-based cancer immunotherapy
6个月前
已完结
Pan-cancer single-cell landscape of tumor-infiltrating T cells
6个月前
已完结
Artificial intelligence in drug development
8个月前
已完结
Antigen-specific profiling identifies T-bet+ melanoma-specific CD8+ T cells associated with response to neoadjuvant PD-1 blockade
8个月前
已完结
皖公网安备34019202002308
